Literature DB >> 11226151

The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface.

J Cladera1, I Martin, P O'Shea.   

Abstract

Studies of the interaction of the 16 residue fusion peptide domain of human immunodeficiency virus glycoprotein gp41 (gp41(FD)) with T lymphocytes are outlined. Fluorescence measurements of changes in the electrostatic surface and dipole potentials of the plasma membrane following the interaction with gp41(FD) are described. The results show that gp41(FD) interacts with heparan sulfate located on the cell surface. This interaction is blocked by interleukin-8 and abolished by pre-treating the cells with heparitinase. The specificity of the reaction was also assessed by observations that soluble heparan sulfate competes with the cell membrane interaction whereas soluble heparin (at the levels utilized) does not. Following binding to heparan sulfate, the interaction with the membrane seems to take place in a cooperative manner with the formation of gp41(FD) trimers. In simpler phospholipid membranes, however, a trimeric complex does not appear to be the dominant mode of interaction. Finally, by repeating some of these studies within an imaging regime, it appears that the gp41(FD)-T-cell interaction takes place within specific domains on the cell surface to similarly localized heparan sulfate moieties.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226151      PMCID: PMC140179          DOI: 10.1093/emboj/20.1.19

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

1.  Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus.

Authors:  M I Vázquez; M Esteban
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.

Authors:  L A Lasky; G Nakamura; D H Smith; C Fennie; C Shimasaki; E Patzer; P Berman; T Gregory; D J Capon
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

3.  The use of fluoresceinphosphatidylethanolamine (FPE) as a real-time probe for peptide-membrane interactions.

Authors:  J Wall; C A Golding; M Van Veen; P O'Shea
Journal:  Mol Membr Biol       Date:  1995 Apr-Jun       Impact factor: 2.857

4.  Identification of the fusion peptide of primate immunodeficiency viruses.

Authors:  M L Bosch; P L Earl; K Fargnoli; S Picciafuoco; F Giombini; F Wong-Staal; G Franchini
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

5.  Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

Authors:  L M Webb; M U Ehrengruber; I Clark-Lewis; M Baggiolini; A Rot
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

6.  Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide.

Authors:  J M Harouse; S Bhat; S L Spitalnik; M Laughlin; K Stefano; D H Silberberg; F Gonzalez-Scarano
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

7.  Dual-wavelength ratiometric fluorescence measurement of the membrane dipole potential.

Authors:  E Gross; R S Bedlack; L M Loew
Journal:  Biophys J       Date:  1994-07       Impact factor: 4.033

8.  Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage.

Authors:  J L Nieva; S Nir; A Muga; F M Goñi; J Wilschut
Journal:  Biochemistry       Date:  1994-03-22       Impact factor: 3.162

9.  Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41.

Authors:  G Roderiquez; T Oravecz; M Yanagishita; D C Bou-Habib; H Mostowski; M A Norcross
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  Interactions of macromolecules with the mammalian cell surface.

Authors:  J Wall; F Ayoub; P O'Shea
Journal:  J Cell Sci       Date:  1995-07       Impact factor: 5.285

View more
  24 in total

1.  Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes.

Authors:  Evelyne Schaeffer; Vanessa B Soros; Warner C Greene
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 2.  Role of heparan sulfate in sexually transmitted infections.

Authors:  Vaibhav Tiwari; Erika Maus; Ira M Sigar; Kyle H Ramsey; Deepak Shukla
Journal:  Glycobiology       Date:  2012-07-06       Impact factor: 4.313

3.  HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation.

Authors:  Francisco J Quintana; Doron Gerber; Sally C Kent; Irun R Cohen; Yechiel Shai
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

Review 4.  Functional imaging of microdomains in cell membranes.

Authors:  James Duggan; Ghadir Jamal; Mark Tilley; Ben Davis; Graeme McKenzie; Kelly Vere; Michael G Somekh; Paul O'Shea; Helen Harris
Journal:  Eur Biophys J       Date:  2008-07-25       Impact factor: 1.733

5.  Small changes in lymphocyte development and activation in mice through tissue-specific alteration of heparan sulphate.

Authors:  Omai B Garner; Yu Yamaguchi; Jeffrey D Esko; Vibeke Videm
Journal:  Immunology       Date:  2008-05-09       Impact factor: 7.397

Review 6.  Extracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery.

Authors:  Helena M van Dongen; Niala Masoumi; Kenneth W Witwer; D Michiel Pegtel
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-02       Impact factor: 11.056

7.  Heparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signaling by thrombospondin-1.

Authors:  Sukhbir Kaur; Svetlana A Kuznetsova; Michael L Pendrak; John M Sipes; Martin J Romeo; Zhuqing Li; Lijuan Zhang; David D Roberts
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

8.  Red Blood Cell Susceptibility to Pneumolysin: CORRELATION WITH MEMBRANE BIOCHEMICAL AND PHYSICAL PROPERTIES.

Authors:  Monika Bokori-Brown; Peter G Petrov; Mawya A Khafaji; Muhammad K Mughal; Claire E Naylor; Angela C Shore; Kim M Gooding; Francesco Casanova; Tim J Mitchell; Richard W Titball; C Peter Winlove
Journal:  J Biol Chem       Date:  2016-03-16       Impact factor: 5.157

9.  Regulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi.

Authors:  Bonnie R Joubert; Nora Franceschini; Victor Mwapasa; Kari E North; Steven R Meshnick
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

10.  Human erythrocytes selectively bind and enrich infectious HIV-1 virions.

Authors:  Zoltan Beck; Bruce K Brown; Lindsay Wieczorek; Kristina K Peachman; Gary R Matyas; Victoria R Polonis; Mangala Rao; Carl R Alving
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.